logo
ResearchBunny Logo
Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine

Medicine and Health

Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine

N. Islam, N. E. Sheils, et al.

This study, conducted by Nazmul Islam, Natalie E. Sheils, Megan S. Jarvis, and Kenneth Cohen, reveals that the mRNA-1273 (Moderna) vaccine offers slightly more protection against SARS-CoV-2 infection compared to the BNT162b2 (Pfizer-BioNTech) vaccine, particularly at 90 days post-vaccination, although both vaccines show similar protection against severe outcomes. Dive into the findings of over 3.5 million fully vaccinated individuals!

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny